Smartronix, Inc. – Trademark Portfolio
Entity Type: 03
Smartronix, Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 12 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include NRG, SMARTRONIX, SMARTRONICS, and MISSION ASSURED. The owner is based in Hollywood, MD.
44150 Smartronix Way
Hollywood, MD 20636
Showing of trademarks Trademarks
Trademark Classifications
Smartronix, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Smartronix, Inc. have?
Smartronix, Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 9 cancelled.
What trademark classes does Smartronix, Inc. file in?
Smartronix, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Smartronix, Inc.'s most well-known trademarks?
Smartronix, Inc.'s registered trademark portfolio includes well-known marks such as NRG, SMARTRONIX, SMARTRONICS, and MISSION ASSURED. These are among 6 currently registered trademarks in the portfolio.
What is Smartronix, Inc.'s trademark registration success rate?
Smartronix, Inc. has a 35% trademark registration rate, with 6 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.